NCT02943304View on ClinicalTrials.gov

Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero

CompletedOBSERVATIONAL
Enrollment

284

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

December 15, 2020

Study Completion Date

December 20, 2022

Conditions
MicrocephalyMental Retardation
Interventions
OTHER

Symptomatic pregnant women with positive RT-PCR ZIKV in serum or urine, or a positive serologic test specific for ZIKV

Trial Locations (1)

68001

Hospital Universitario de Santander, Bucaramanga

All Listed Sponsors
collaborator

University of North Carolina, Chapel Hill

OTHER

lead

Universidad Industrial de Santander

OTHER

NCT02943304 - Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero | Biotech Hunter | Biotech Hunter